Rheumatology session-1: Precision medicine in Rheumatology : from biomarker to patient, integrating the gender perspective.
Tracks
Track 1
| Wednesday, June 3, 2026 |
| 1:30 PM - 3:00 PM |
Details
ORGANIZERS
ESCI Council: Elisa Llurba and Carlos Zaragoza
Invited Organizer(s): Fernando M. Pimentel-Santos and Cristina Ponte
Speaker
Ali Mobasheri
Professor Of Musculoskeletal Biology
University of Oulu
Primary Prevention in Motion: Targeting Cartilage Health to Halt Osteoarthritis Before it Starts
1:30 AM - 1:50 AMBiography
Ali Mobasheri is Professor of Musculoskeletal Biology in the Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Finland. He also serves as Chief Researcher and International Adviser at the State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. He was President of the Osteoarthritis Research Society International (OARSI) from May 2019 until April 2022. He currently sits on the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). He is also an advisor to the World Health Organization Collaborating Center for Epidemiology of Musculoskeletal Conditions and Ageing, Université de Liège, Liège, Belgium. His research focuses on cartilage biology and osteoarthritis biomarkers. He has published more 450 scientific articles and has an h-index of 80 (Scopus).
ORCID iD: 0000-0001-6261-1286
orcid.org/0000-0001-6261-1286
Scopus Author Identifier: 7003311894
www.scopus.com/authid/detail.uri?authorId=7003311894
Ali Mobasheri
Professor Of Musculoskeletal Biology
University of Oulu
Staying Young at an Advanced Age: The Impact of Emerging Therapeutic Approaches in Osteoarthritis.
1:30 PM - 1:50 PMBiography
Ali Mobasheri is Professor of Musculoskeletal Biology in the Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Finland. He also serves as Chief Researcher and International Adviser at the State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. He was President of the Osteoarthritis Research Society International (OARSI) from May 2019 until April 2022. He currently sits on the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). He is also an advisor to the World Health Organization Collaborating Center for Epidemiology of Musculoskeletal Conditions and Ageing, Université de Liège, Liège, Belgium. His research focuses on cartilage biology and osteoarthritis biomarkers. He has published more 450 scientific articles and has an h-index of 80 (Scopus).
ORCID iD: 0000-0001-6261-1286
orcid.org/0000-0001-6261-1286
Scopus Author Identifier: 7003311894
www.scopus.com/authid/detail.uri?authorId=7003311894
Fernando Pimentel
Rheumatoid arthritis and Spondyloarthritis, past, present, and future perspectives of treatment
1:50 PM - 2:10 PMBiography
Ana Rodrigues
An Anti-Fracture Strategy for Healthy Ageing, the contribute of new biomarkers.
2:10 PM - 2:30 PMBiography
Maftuna Abdulloeva
Assistant
Samarkand State Medical University
Improving the Efficiency of Rheumatologic Care Delivery to the Population through the Implementation of Modern Diagnostic and Digital Technologies
2:30 PM - 2:40 PMBiography
Mohigul Bekkulova
Doctor
Fergana State Medical Institute
CLINICAL FEATURES OF RHEUMATOID ARTHRITIS IN PEOPLE OVER SIXTY AGE
2:40 PM - 2:50 PMBiography
Chair
Elisa Llurba
Head Of Department
Sant Pau Hospital
Carlos Zaragoza
|
